key: cord-0048995-249gx9ys
authors: Dashraath, Pradip; Jeslyn Wong, Jing Lin; Su, Lin Lin
title: COVID-19 pandemic and pregnancy – posology and cardiometabolic pathology
date: 2020-08-21
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.08.046
sha: b53a0547a6f7bb67fd6fb3bd45236ac7af078cac
doc_id: 48995
cord_uid: 249gx9ys

nan

We thank Carbillon and co-workers for their perspectives on the optimal dose of chloroquine in pregnancy. The novel use of chloroquine phosphate and hydroxychloroquine in the management of COVID-19 is an area of evolving research. Our rationale for high-dose chloroquine was based, at the time, on expert consensus from the Chinese Ministry of Health and data from the interim analysis of a study by the Health Commission of Guangdong province, China which supported the use of a twice-daily 500 mg regime in the clinical management of COVID-19. 1 However, important findings from a subsequent double-masked, randomized phase IIb clinical trial from Brazil (ClinicalTrials.gov number NCT 04323527), of adults with severe COVID-19, have since demonstrated that high-dose chloroquine is associated with greater toxicity and mortality from QTc prolongation. 2 While these results are not generalizable across the COVID-19 disease spectrum, we now caution against the use of high-dose regimes and advise providers to consult their institutional protocols when considering these drugs as a treatment option in pregnancy.

Rancourt and colleagues astutely highlight the influence of body mass index (BMI) on disease outcomes. Although anthropometric data of pregnant women with COVID-19 were not available during the initial stages of the pandemic, obesity is now a well-recognized risk factor for severe SARS-CoV-2 infection. 3 It is believed that obesity attenuates cardiorespiratory reserves and amplifies circulating serum interleukin-6 levels -the latter, by instigating a cytokine storm, results in a significantly elevated risk of severe disease and mortality from COVID-19. 3, 4 Pregnant women who are obese and battling COVID-19 would therefore find themselves between Scylla and Charybdis, where gravid physiology and disease pathology collide to encourage progression to critical illness.

J o u r n a l P r e -p r o o f

Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia

Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial

Obesity is a risk factor for severe COVID-19 infection

Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: a systematic review

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study